PBPK Modelling of. Food Effects. PBPK SYMPOSIUM 2018 Paris, April 4 th David Turner (Presented by Dr Sebastian Polak)
|
|
- Annis Veronica Kelley
- 5 years ago
- Views:
Transcription
1 PBPK Modelling of Food Effects PBPK SYMPOSIUM 2018 Paris, April 4 th 2018 David Turner (Presented by Dr Sebastian Polak) david.turner@certara.com
2 Outline Modelling of Food Effects with Population PBPK Models Summary of Food Effects Currently Handled Mechanisms Gaps and Issues Summary 2
3 Oral Absorption: ADAM Framework & Population Variability Regional Mean and Inter-individual Variability of: ph, [bile salts], fluid volumes, viscosity, [bicarbonate], gut wall morphology, blood flow, etc. Regional Mean and Inter-individual Variability of Derived Parameters: bulk solubility, surface solubility, free fraction, dissolution rate, permeation rate, metabolism etc. 100 simulated subjects CAT : Lu et al., 1996; ACAT: Agoram et al., 2001; ADAM: Jamei et al.,
4 Effect of Food on Physiological Parameters Available in Simcyp ph IMMC Cycle (EHC model) Bile Salts Conc. Effect of Food Luminal Fluid Viscosity Fluid Volume Dynamics Buffer Capacity Transit Times Splanchnic Blood Flow
5 1. ph Gastric ph Change / Return Time to Fasted Gastric ph after Food Gastric ph rises with food (NEC HV Population representative) Gastric ph vs. Time T ff : the period during which the stomach ph returns to the fasted ph (h): (mean ± CV%) ph Young: 1.8h±65 Elderly: 3h±80 If age i < 65: ph ST,t = ph ST,fed,i e -kt Otherwise (age i >= 65): ph ST,t (T ff t) ( ph ST,fed,i T ff - ph ph ST,fasted,i ST,fasted,i ) Data from Russell et al Time After Meal (mins.)
6 1. ph Fasted and Fed ph (dynamic, modifiable V18) 6
7 2. GIT Transit of Drug / Formulation Segregated Transit Model Formulation tabs Substrate and Inhibitor Independent (except fluid with dissolved drug) 7
8 2. GIT Transit Complication: Gastric Emptying Fed State Magenstrasse Gastric emptying and intestinal transit measurements should be of the drug and/or formulation not the food itself Fed state gastric emptying is generally assumed slower than fasted BUT The Magenstrasse (stomach road) describes the fast emptying of ingested liquids from the postprandial stomach. The occurrence of the Magenstrasse has great importance for drugs administered together with food as it represents a shortcut through the fed stomach and allows rapid onset of plasma levels. (Provided dissolution in the stomach is sufficiently rapid) the effect of fat content of the meals (on the Magenstrasse) was negligible 8
9 3. Simulated Dynamic Luminal Fluid Volumes: Fed State Multiple Doses, each after food V fluid,stomach, t=0 = Fluid in Food + Fluid in Drink + Baseline fluid = ~840 ml (PopRep) 9
10 3. Fed State Intestinal Fluid Volume Dynamics are Poorly Understood Grimm, Weitschies 2017 MolPharm
11 3. Fed State Intestinal Fluid Volume Dynamics are Poorly Understood 11 subjects 8 m / 3 fe years BMI MRI imaging at 1 hr intervals Meal: High Fat LBG locust bean gum Fasted Base line ml These high-fat meals stimulated substantial increases in SBWC, which increased to a peak at 4 h at 568 ml Highly variable between subjects: peak ml. * Hussein, Marciani et al
12 3. Fed State Intestinal Fluid Volume Dynamics are Poorly Understood 11 subjects 8 m / 3 fe years BMI MRI imaging at 1 hr intervals Meal: High Fat LBG locust bean gum Fasted Base line ml These high-fat meals stimulated substantial increases in SBWC, which increased to a peak at 4 h at 568 ml Highly variable between subjects: peak ml. * Hussein, Marciani et al
13 3. FDA Standard High Fat Meal However, to the best of our knowledge, the small intestinal fluid dynamics after the FDA standard breakfast were not investigated so far. Koziolek, Weitschies 2016 Adv Drug Del Reviews Also, confirmed (March 2018) by Prof Luca Marciani (University of Nottingham) Gastric fluid volume dynamics with standard high fat meal Simcyp V18 13
14 4. Food Effects Bile Salt Concentrations FASTED FED Luminal Bile Conc. (mm) 10 5 CMC < 1 mm 0 Stomach Jejunum I Duodenum Jejunum II Ileum I Ileum II Ileum III Ileum IV Colon 1-Kalantzi et al. 2006; 2-Mithani et al. 1996; 3-Zimmermann et al. 1994; 4-Barnwell et al and others Mean, CV and regional differences saved in Simcyp Population File Fed is medium to high fat conditions
15 4. Food Effects Predicting Drug Partition into Bile Salt Micelles A model is required to capture inter-individual variability of ph and [bile salt] Binding to micelles is characterised by a micelle:aqueous partition coefficient (K m:w ) IF [Bile Salts] > CMC (Critical Micelle Concentration) ELSE S (BS)Tot = So + S ionised where S ionised = So 10 pka-ph Glomme, März, Dressman (2004) e.g., for a Monoprotic Base Micelle partition coefficients (K m:w ) predicted from logp o:w or estimated from modelling of in vitro solubility experiments (SIVA Toolkit)
16 4. Impact of Micelle Partition upon Solubility and Dissolution Rate Effective Diffusion Coefficient (D eff ) is reduced where there is significant bile micelle partition D eff = f neutral D neutral + f ion D ion + f micelle D micelle D micelle = 0.78 D neutral = 4.4 x 10-4 cm 2 /min (typical micelle) (small molecule with MWt around 350 Da) 5 4 Typical Calculated D eff vs. [Bile Salts] Profile D eff (10-4 cm 2 / min) [Bile Salts] (mm)
17 5. Food Viscosity Food can impact disintegration and dissolution rate Food viscosity may impact diffusivity (D eff ) and h eff hence dissolution rate Requires Fluid Dynamics Model to be Active (Particle Motion Equations) Assumes gastric contents are well-mixed (but Magenstrasse) Dynamic Viscosity based upon dilution to be added to Simcyp V18
18 5. Accounting for Hydrodynamics: Effective Diffusion Layer Thickness, h eff DR(t) i 1 NBINs Deff ( t) N i S 4 ai ( t) ai ( t) heff, i ( t) (Ssurface Cbulk ( t) ) h ( t) eff, i Fluid Dynamics h eff Equations radius viscosity shear D eff = f aq,n D mono,n + f aq,ion D mono,ion + f micelle D micelle Effective Diffusion Coefficients Re total Sc Sh f 2a( t) U f U p f f D eff D f eff 1/ 2 1/ Re Sc h eff 2a( t) Sh Relative Velocity Terms? Complex CFD Modelling Representative Velocities (USP2, µdiss) (axial and tangential) CFD models: USP 2: Bai et al µdiss: Johansson et al
19 6. Time-dependent Fed State Intestinal Blood Flow Splanchnic Blood Flow Increase for duration of fed state Clinical Studies Mean & SD Splanchnic Fed/Fasted Blood Flow Ratio Simulations Solid line Mean prediction Dashed lines 5 th and 95 th percentiles 100 healthy volunteers Time (h) after Meal Rose et al The AAPS Journal
20 6. Blood Flow Supply to Small Intestine Evidence: Reports indicating reduced hepatic extraction ratio for high extraction compounds such as propranolol. Accounting for the time-dependent change in splanchnic blood flow is important to recover the increase in exposure to orally administered high extraction compounds in the fed state. Time-independent increase in blood flow Fed/fasted ratio: AUC = 1.01 C max = 1.14 Time-dependent increase in blood flow Fed/fasted ratio: AUC = 1.28 C max = 1.32 Rose et al. ACoP, Las Vegas, USA, Oct 2014; Rose, Turner et al., 2017 AAPS Journal
21 7. Buffer Capacity Particle Surface ph Particularly in the fasted state buffer capacity is low Particle surface ph reduced (acidic dugs), increased (basic drugs) Particle surface solubility reduced and dissolution rate If surface ph is not accounted for in the fasted state then fasted-fed differences may not be picked up Cristofoletti and Dressman 2016 J Pharm Sci 105(12):
22 7. MechPeff Model ONLY Way to Capture Free Fraction driving Permeation Solid Drug Gut Lumen Lumen Wall Unstirred Boundary Layer (UBL) Enterocytes Dissolution 1) Free Fraction = non-micelle bound fraction Free fraction = 1 f micelle Food [bile] f micelle 2) Luminal Wall UBL Permeability (P UBL ) Food f micelle D eff,ubl P UBL P eff (ONLY if P eff is UBL limited High Permeability Drugs) Adapted from Sugano 2009 Interplay!
23 8. Enterohepatic Recirculation Model (Gallbladder Kinetics) Kinetics of drug in bile differ according fasted or fed state Dose Given Fasted state simulation assumed to start at a random point during the IMMC GB Emptying, No Accumulation in GB GB Accumulation + intermittent GB Emptying Second and subsequent doses are assumed to be taken after additional food and the process returns to Start Fed State 23
24 Dynamic Bile Salt Model (Simcyp V18 preliminary results) Fully integrated with (and inter-dependent on) dynamic fluid volumes model 24
25 Wide variability in nature and extent of FE for CR Formulations Clinically Observed FE with CR Formulations of Nifedipine QSAR or classifier models cannot predict FE for CR/MR formulations as they are based on the drug (API) rather than the formulation Data: Toal, 2012, IJCPT
26 Zolpidem Negative Food Effect Attributed to Uncharacterized Impact of Meal on Release from Formulation 26
27 Way forward - Dynamic Viscosity-Disintegration Model: Negative Food Effects`` Relationship between Disintegration Constant and Viscosity Viscosity changes predicted using ADAM fluid volume dynamics model ADAM PBPK Model Predicted in vivo disintegration profile Negative food effect of Trospium chloride Poster: Orbito 2015; ms. in prep
28 Case Study: Simulating Food Effects Precipitating Compounds Cristofoletti et al Ketoconazole Posaconazole Fasted Fed Fed Fasted Predict-learn-confirm model development process Estimated precipitation kinetics parameters using fasted PK data and used to predict fed state
29 FDA View / ASCPT Paper The published literature and perhaps also the results from submissions to the FDA may be biased, because only the good results tend to be published or submitted, whereas the true picture may be lost 29
30 Some Issues Raised by Li et al The food effect may affect intestinal enzymes and transporters. Comment: The mechanisms are available in PBPK models but not the required kinetic data and (unbound) amounts of various active components in a particular meal (if the active component is digestible or absorbable there is an extra issue). The mobility of food components is largely affected by the presence of fluids in the GI tract. Comment: Food effects on luminal fluid volumes are highly variable and depend on the composition of the meal (see slides). There are no published data on small intestinal fluid volumes even after a standard FDA meal. Especially for highly permeable weak bases, in vitro setups to measure precipitation, such as the transfer model, were demonstrated to over-predict the extent of precipitation in vivo. Comment: Hens et al, 2017 Mol Pharmaceut 14(12):4321 demonstrate with posaconazole BCS 2 (fasted conditions) that over-prediction can be avoided with suitable in vitro data, suitable models and modelling of the IN VITRO data (SIVA Toolkit) prior to PBPK modelling. 30
31 Summary Food Effects Are complex and either not well understood or not well characterised even for a standard FDA high fat meal Can be assessed in complex experiments such as the TNO TIM Mechanistic models are required to extrapolate to different regions of the GIT, individuals and different populations Mechanistic modelling of complex TNO TIM type experiments is very difficult or impossible; it makes sense to simplify experiments such that mechanisms and parameters can be captured by modelling of those experiments: - requires a range of suitable experiments to be identified and performed - provides mechanistic understanding Population Variability Many (most?) physiological parameters associated with the GIT have high intersubject variability (and sometimes intra-subject variability) so it makes sense to simulate virtual clinical trials rather than a single average subject. 31
32 Some Publications: Food Effects Cristofoletti Patel N, Dressman JB (2016) Assessment of Bioequivalence of Weak Base Formulations Under Various Dosing Conditions Using Physiologically Based Pharmacokinetic Simulations in Virtual Populations. Case Examples: Ketoconazole and Posaconazole. J Pharm Sci 106(2): 560. Cristofoletti R, Patel N, Dressman JB (2016) Differences in Food Effects for 2 Weak Bases With Similar BCS Drug- Related Properties: What Is Happening in the Intestinal Lumen? J Pharm Sci. 105(9):2712. Andreas CJ, Pepin X, Markopoulos C, Vertzoni M, Reppas C, Dressman JB (2017) Mechanistic investigation of the negative food effect of modified release zolpidem. Eur J Pharm Sci. 102: Patel N, Polak S, Jamei M, Rostami Hodjegan A, Turner DB (2013) Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: A case study using BCS/BDDCS Class II drug Nifedipine. Eur J Pharm Sci Rose RH, Turner DB, Neuhoff S, Jamei M (2017) Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs. AAPS J 19(4): Modelling In Vitro Experiments Pathak S, Ruff A, Kostewicz ES, Patel N, Turner DB, Jamei M (2017) Model-based Analysis of Biopharmaceutical Experiments to Improve Mechanistic Oral Absorption Modelling - An Integrated in Vitro in Vivo Extrapolation (IVIV_E) Perspective using Ketoconazole as a Model Drug. Mol Pharmaceut 14(12): Hens B, Pathak SM, Mitra A, Patel N, Liu B, Jamei M, Brouwers J, Augustijns P, Turner DB (2017) In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation and Precipitation of Posaconazole: A Simulation Study Using the Physiologically-Based ADAM Model. Mol Pharmaceut 14(12): Simcyp ADAM Model Jamei M, Turner D, Yang J, Neuhoff S, Polak S, Rostami-Hodjegan A, Tucker G. Population-based Mechanistic Prediction of Oral Drug Absorption AAPS J. 2009, 11(2):
33 Acknowledgements Simcyp Team (Oral absorption / Gut Wall) Nikunj Patel, Shriram Pathak, Masoud Jamei, Deven Pade, Ali Nimavardi, Sumit Arora, Kostas Stamatopoulos, Sibylle Neuhoff, Matt Harwood, Oliver Hatley, Sebastian Polak Parts of this work has received support from the Innovative Medicines Initiative Joint Undertaking ( under grant agreement n , resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/ ) and EFPIA companies in kind contribution. 33
In silico tools to simulate the regional differences of the human GI tract. Konstantinos Stamatopoulos Simcyp Limited (A Certara Company)
In silico tools to simulate the regional differences of the human GI tract Konstantinos Stamatopoulos Simcyp Limited (A Certara Company) Ungap meeting, Leuven, March 2018 Available Tools 2 Oral Absorption:
More informationAdvantages and Limitations of In Vivo Predictive Dissolution (IPD) Systems
Advantages and Limitations of In Vivo Predictive Dissolution (IPD) Systems November 16 th Prof. Gregory E. Amidon - University of Michigan What is an In vivo Predictive Dissolution (IPD) System? An IPD
More informationAdvantages and Limitations of In Vivo Predictive Dissolution (IPD) Systems
Advantages and Limitations of In Vivo Predictive Dissolution (IPD) Systems November 16 th Prof. Gregory E. Amidon - University of Michigan What is an In vivo Predictive Dissolution (IPD) System? An IPD
More informationPK-UK Challenges and benefits of using PBPK to evaluate an IVIVC for drugs with nonideal solubility and/or permeability. Bath, November 2014
PK-UK 2014 Challenges and benefits of using PBPK to evaluate an IVIVC for drugs with nonideal solubility and/or permeability Bath, November 2014 Prof. Dr. Jennifer Dressman Dressman Bath 2014 Why IVIVC
More informationAdvances in Prediction of Food Effects
Advances in Prediction of Food Effects John Crison APS Biopharmaceutics Focus Group MSD Innovation Centre, Hoddesdon, UK June 9, 2011 Outline Introduction/Theory Physiological and Physical Chemical Parameters
More informationAltered GI absorption in special populations: An industry perspective
Altered GI absorption in special populations: An industry perspective Cordula Stillhart and Neil J. Parrott F. Hoffmann La Roche Ltd, Basel (CH) UNGAP WG meeting, Leuven (B) 8 March 2018 Current challenges
More information1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small
Lecture-5 1. Gastric Emptying Time Anatomically, a swallowed drug rapidly reaches the stomach. Eventually, the stomach empties its content in the small intestine. Because the duodenum has the greatest
More informationDevelopment of Canagliflozin: Mechanistic Absorption Modeling During Late-Stage Formulation and Process Optimization
Development of Canagliflozin: Mechanistic Absorption Modeling During Late-Stage Formulation and Process Optimization Nico Holmstock Scientist, Janssen R&D M CERSI 2017, BALTIMORE (USA) Canagliflozin An
More information2- Minimum toxic concentration (MTC): The drug concentration needed to just produce a toxic effect.
BIOPHARMACEUTICS Drug Product Performance Parameters: 1- Minimum effective concentration (MEC): The minimum concentration of drug needed at the receptors to produce the desired pharmacologic effect. 2-
More informationViera Lukacova Director, Simulation Sciences
Use of In Silico Mechanistic Models to Support Interspecies Extrapolation of Oral Bioavailability and Formulation Optimization: Model Example Using GastroPlus Viera Lukacova Director, Simulation Sciences
More informationUSING PBPK MODELING TO SIMULATE THE DISPOSITION OF CANAGLIFLOZIN
USING PBPK MODELING TO SIMULATE THE DISPOSITION OF CANAGLIFLOZIN Christophe Tistaert PDMS Pharmaceutical Sciences Preformulation & Biopharmaceutics AAPS 2015, FLORIDA (USA) Canagliflozin An orally active
More informationPQRI Workshop Bethesda 2012
Review of GI physiology and use of biorelevant media PQRI Workshop Bethesda 2012 Prof. Dr. Jennifer Dressman An IVIVC can only be as good as the data used to produce it! With respect to the dissolution
More informationSaliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System
Drugs R D (2015) 15:79 83 DOI 10.1007/s40268-015-0080-1 ORIGINAL RESEARCH ARTICLE Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion
More informationOral Drug Delivery: What to learn from Imaging Studies? An update. Werner Weitschies University of Greifswald
Oral Drug Delivery: What to learn from Imaging Studies? An update Werner Weitschies University of Greifswald werner.weitschies@uni-greifswald.de 8th Global DDF Summit, Berlin, March 28, 2017 Outline Methodologies
More informationModeling Dynamic Gastrointestinal Fluid Transit as a Basis for Dissolution and Absorption
Modeling Dynamic Gastrointestinal Fluid Transit as a Basis for Dissolution and Absorption Duxin Sun, Ph.D. William I. Higuchi Collegiate Professor Department of Pharmaceutical Sciences Pharmacokinetics
More informationPharmacokinetic Modeling & Simulation in Discovery and non-clinical Development
Pharmacokinetic Modeling & Simulation in Discovery and non-clinical Development Where do we stand? Disclaimer I am not a bioinformatician, mathematician or biomedical engineer. I am a simple minded pharmacist,
More informationDefine the terms biopharmaceutics and bioavailability.
Pharmaceutics Reading Notes Define the terms biopharmaceutics and bioavailability. Biopharmaceutics: the area of study concerning the relationship between the physical, chemical, and biological sciences
More informationUSE OF BIO-PREDICTIVE METHODS DURING EARLY FORMULATION SCREENING
USE OF BIO-PREDICTIVE METHODS DURING EARLY FORMULATION SCREENING Jesse L. Kuiper, Ph.D. (Merck) Carrie A. Coutant, Ph.D. (Eli Lilly) Merck Research Laboratories 15-May-2017 1 Acknowledgements 1X Dissolution
More informationThe BCS: Where Do We Go from Here?
The BCS: Where Do We Go from Here? Jennifer Dressman,* James Butler, John Hempenstall, and Christos Reppas Since the Biopharmaceutics Classification System (BCS) was introduced several years ago, it has
More informationMetformin: Mechanistic Absorption Modeling and IVIVC Development
Metformin: Mechanistic Absorption Modeling and IVIVC Development Maziar Kakhi *, Ph.D. FDA Silver Spring, MD 20993 Maziar.kakhi@fda.hhs.gov Viera Lukacova, Ph.D. Simulations Plus Lancaster, CA 93534 viera@simulations-plus.com
More informationFed and Fasted Conditions Dissolution Studies
Fed and Fasted Conditions Dissolution Studies Prof. Dr. Nevin ÇELEBİ Gazi University Faculty of Pharmacy Department of Pharmaceutical Technology-Ankara/TURKEY E-mail:ncelebi@gazi.edu.tr Int.Symp.Dissolution
More informationSimulating the lower intestine based on in vivo data
HELLENIC REPUBLIC National & Kapodistrian University of Athens SCHOOL OF HEALTH SCIENCES FACULTY OF PHARMACY Dpt of Pharmaceutical Technology Simulating the lower intestine based on in vivo data Christos
More informationAug 28 th, 2017 Pierre Daublain
Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species to Inform Derisking Strategies in Discovery and Early Development Aug 28 th, 2017 Pierre Daublain Outline Problem
More informationPhysiology 12. Overview. The Gastrointestinal Tract. Germann Ch 19
Physiology 12 The Gastrointestinal Tract Germann Ch 19 Overview 1 Basic functions of the GI tract Digestion Secretion Absorption Motility Basic functions of the GI tract Digestion: : Dissolving and breaking
More informationBiopharmaceutics. Lec: 4
64 Biopharmaceutics Physicochemical Properties of Drugs Affecting Bioavailability Lec: 4 1 Assist. Lecturer Ali Yaseen Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School
More informationGastric, intestinal and colonic absorption of metoprolol in
Br. J. clin. Pharmac. (1985), 19, 85S-89S Gastric, intestinal and colonic absorption of metoprolol in the rat J. DOMENECH', M. ALBA', J. M. MORERA', R. OBACH' & J. M. PLA DELFINA2 'Department of Pharmaceutics,
More informationBiopharmaceutics Dosage form factors influencing bioavailability Lec:5
Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019
More informationExcipient Interactions Relevant For BCS Biowaivers Peter Langguth
Excipient Interactions Relevant For BCS Biowaivers Peter Langguth Department of Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg University Mainz, Germany 3rd Symposium on Harmonization
More informationSummary and general discussion
Summary and general discussion Ingestion of contaminated soil can be an important route of exposure to soil-borne contaminants, especially for children (1). To estimate the health risk associated to this
More informationHTPK: Conducting PK modeling and
HTPK: Conducting PK modeling and simulations at high speed November 5, 2018 Robert Fraczkiewicz, David Miller, Marvin Waldman, Robert D. Clark Slide 1 Session Description and Objectives HTPK lightens the
More informationLecture 1: Physicochemical Properties of Drugs and Drug Disposition
Lecture 1: Physicochemical Properties of Drugs and Drug Disposition Key objectives: 1. Be able to explain the benefits of oral versus IV drug administration 2. Be able to explain the factors involved in
More informationOverview. Physiology 1. The Gastrointestinal Tract. Guyton section XI
Overview Physiology 1 The Gastrointestinal Tract Guyton section XI Basic functions of the GI tract Digestion Secretion Absorption Motility Basic functions of the GI tract Digestion: : Dissolving and breaking
More informationSection Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, ,
IDP Biological Systems Gastrointestinal System Section Coordinator: Jerome W. Breslin, PhD, Assistant Professor of Physiology, MEB 7208, 504-568-2669, jbresl@lsuhsc.edu Overall Learning Objectives 1. Characterize
More informationUse of PBPK in simulating drug concentrations in pediatric populations: Case studies of Midazolam and Gabapentin
Use of PBPK in simulating drug concentrations in pediatric populations: Case studies of Midazolam and Gabapentin WORKSHOP ON MODELLING IN PAEDIATRIC MEDICINES April 2008 Viera Lukacova, Ph.D. Walter Woltosz,
More informationDetail features... 1
PBPK Modelling and its Applications to Predict Transporter-Mediated Drug-Drug Interactions Masoud Jamei Senior Scientific Advisor, Head of M&S M.Jamei@Simcyp.com NEDMDG 14 th June 211, New England, USA
More informationWHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION
PHARMACOKINETICS I Absorption & Distribution LEARNING OUTCOMES By the end of the lecture students will be able to.. Dr Ruwan Parakramawansha MBBS, MD, MRCP(UK),MRCPE, DMT(UK) (2013/08/21) Define pharmacokinetics,
More informationMechanistic Transport Analysis to Predict In Vivo Oral Bioperformance. Deanna M. Mudie
Mechanistic Transport Analysis to Predict In Vivo Oral Bioperformance by Deanna M. Mudie A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Pharmaceutical
More informationUnderstand the physiological determinants of extent and rate of absorption
Absorption and Half-Life Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand Objectives Understand the physiological determinants of extent and rate of absorption
More informationConferencia Inaugural
Conferencia Inaugural UNDERSTANDING GASTRIC DIGESTION TO DEVELOP NEW FOODS FOR HEALTH R. Paul Singh Distinguished Professor of Food Engineering Department of Biological and Agricultural Engineering University
More informationOsnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne,
Osnove farmakokinetike Aleš Mrhar Prirejeno po A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne, College of Pharmacy, University of Oklahoma Pharmacokinetics/Pharmacodynamics Pharmacodynamics
More informationOral Formulations for Poorly Water Soluble Compounds. SAQ - Fachgruppe Pharma & Chemie Oskar Kalb, Novartis Pharma AG Basel Olten, 23.
Oral Formulations for Poorly Water Soluble Compounds SAQ - Fachgruppe Pharma & Chemie Oskar Kalb, Novartis Pharma AG Basel Olten, 23. June 2009 Oral Delivery of Poorly Water Soluble Compounds For systemic
More informationPhysiologically relevant in vitro methodology to determine true digestibility of carbohydrates and to predict the glycaemic response
Physiologically relevant in vitro methodology to determine true digestibility of carbohydrates and to predict the glycaemic response TNO Quality of Life, Zeist, The Netherlands TIM-Carbo Robert Havenaar
More informationBASIC PHARMACOKINETICS
BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter
More information4. ABSORPTION. Transport mechanisms. Absorption ABSORPTION MECHANISMS. Active transport. Active transport uses metabolic energy
4. ABSORPTION ABSORPTION MECHANISMS Once the digestive process is completed, the nutrients have to be transferred across the digestive tract epithelium into the intracellular space and eventually into
More informationDESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE
1. Introduction: DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE Oral controlled - release formulations for the small intestine and colon have received considerable
More informationBIOPHARMACEUTICS and CLINICAL PHARMACY
11 years papers covered BIOPHARMACEUTICS and CLINICAL PHARMACY IV B.Pharm II Semester, Andhra University Topics: Absorption Distribution Protein binding Metabolism Excretion Bioavailability Drug Interactions
More informationSimilar or Not? Comparison of Dissolution Profiles of Different Hydroxypropylmethyl Cellulose (HPMC) Capsules
dx.doi.org/.4227/dt258p6 Similar or Not? Comparison of Dissolution Profiles of Different Hydroxypropylmethyl Cellulose (HPMC) Capsules Jozef Al-Gousous, Michael B. Bolger2, Fernando Diez3, Justin Kalafat3,
More informationA Novel Mechanistic and Physiologically-Based Pharmacokinetic Model with Dynamic Gastrointestinal Fluid Transport
A Novel Mechanistic and Physiologically-Based Pharmacokinetic Model with Dynamic Gastrointestinal Fluid Transport by Alex Yu A dissertation submitted in partial fulfillment of the requirements for the
More informationOat beta glucan: Multiple roles in the gut. A.R. Mackie, B.H. Bajka, B. Kirkhus
Oat beta glucan: Multiple roles in the gut A.R. Mackie, B.H. Bajka, B. Kirkhus Introduction Food is consumed Food resides in the stomach Chyme is gradually emptied into the duodenum Can oat beta glucan
More informationDetermination of bioavailability
Pharmaceutics 2 Bioavailability Bioavailability is the rate and extent to which an administered drug reaches the systemic circulation. For example, if 100 mg of a drug is administered orally and 70 mg
More informationSimulation of the Nonlinear PK of Gabapentin and Midazolam in. Adult and Pediatric Populations. Population Approach Group in Europe (PAGE)
Simulation of the Nonlinear PK of Gabapentin and Midazolam in Adult and Pediatric Populations Population Approach Group in Europe (PAGE) Meeting June 2006 Brugge, Belgium Walter Woltosz, M.S., M.A.S. Viera
More informationIs the science that study relation of physicochemical properties of drug, dosage form, & route of administration on rate and extent of drug
Chapter 5 Is the science that study relation of physicochemical properties of drug, dosage form, & route of administration on rate and extent of drug absorption. It is the study of the kinetics of absorption,
More informationUNIVERSITY OF THE WEST INDIES, ST AUGUSTINE
UNIVERSITY OF THE WEST INDIES, ST AUGUSTINE FACULTY OF MEDICAL SCIENCES SCHOOL OF PHARMACY BACHELOR OF SCIENCE IN PHARMACY DEGREE COURSE SYLLABUS COURSE TITLE: COURSE CODE: BIOPHARMACEUTICS, NEW DRUG DELIVERY
More informationNOTES: The Digestive System (Ch 14, part 2)
NOTES: The Digestive System (Ch 14, part 2) PANCREAS Structure of the pancreas: The pancreas produces PANCREATIC JUICE that is then secreted into a pancreatic duct. The PANCREATIC DUCT leads to the The
More informationMechanistic Studies and Modeling of Effects of Ingested Lipids on Oral Drug Absorption. A Thesis Presented. Selena Di Maio
Mechanistic Studies and Modeling of Effects of Ingested Lipids on Oral Drug Absorption A Thesis Presented By Selena Di Maio to The Department of Chemical Engineering In partial fulfillment of the requirements
More informationMany drugs have both lipophilic and hydrophilic chemical substituents. Those drugs that are more lipid soluble tend to traverse cell membranes more
Lecture-4 Many drugs have both lipophilic and hydrophilic chemical substituents. Those drugs that are more lipid soluble tend to traverse cell membranes more easily than less lipid-soluble or more water-soluble
More informationThe use of Saliva instead of Plasma as a Surrogate in Drug Bioavailability and Bioequivalence Studies in Humans
The use of Saliva instead of Plasma as a Surrogate in Drug Bioavailability and Bioequivalence Studies in Humans ا.د. ناصر محمد ياسر نمرادكيدك Prof. Nasir M. Idkaidek University of Petra Amman - Jordan
More informationFundamentals of Pharmacology for Veterinary Technicians Chapter 4
(A) (B) Figure 4-1 A, B (C) FIGURE 4-1C The active transport process moves particles against the concentration gradient from a region of low concentration to a region of high concentration. Active transport
More informationPharmacokinetics I. Dr. M.Mothilal Assistant professor
Pharmacokinetics I Dr. M.Mothilal Assistant professor DRUG TRANSPORT For a drug to produce a therapeutic effect, it must reach to its target and it must accumulate at that site to reach to the minimum
More information4 Development of an ESR online-method for the monitoring of in vitro fat digestion
4 Development of an ESR online-method for the monitoring of in vitro fat digestion 4.1 Introduction When regarding the oral administration of lipid-based nanocapsules, gastrointestinal digestion will play
More informationChapter 3 Drug Absorption and Bioavailability
Chapter 3 Drug Absorption and Bioavailability Debra Si Mui Sim Abstract Most drugs are prescribed as oral preparations or extravascular injections (other than intravenous injections) for the treatment
More informationExploiting BDDCS and the Role of Transporters
Exploiting BDDCS and the Role of Transporters (Therapeutic benefit of scientific knowledge of biological transporters, understanding the clinical relevant effects of active transport on oral drug absorption)
More informationBiopharmaceutics Drug Disposition Classification System (BDDCS) --- Its Impact and Application
Biopharmaceutics Drug Disposition Classification System (BDDCS) --- Its Impact and Application Leslie Z. Benet, Ph.D. Professor of Bioengineering and Therapeutic Sciences Schools of Pharmacy and Medicine
More informationAssem Al Refaei. Sameer Emeish. Dr.Alia. Hodaifa Ababneh & Abdullah Shurafa
8 Assem Al Refaei Sameer Emeish Hodaifa Ababneh & Abdullah Shurafa Dr.Alia Sheet Checklist Bioequivalence and Therapeutic equivalence. Factors Influencing Absorption. Revising Bioavailability. Factors
More informationMuhammad Fawad Rasool Feras Khalil Stephanie Läer
Clin Pharmacokinet (2015) 54:943 962 DOI 10.1007/s40262-015-0253-7 ORIGINAL RESEARCH ARTICLE A Physiologically Based Pharmacokinetic Drug Disease Model to Predict Carvedilol Exposure in Adult and Paediatric
More informationBiorelevant dissolution of candesartan cilexetil
ADMET & DMPK 5(1) (2017) 39-46; doi: 10.5599/admet.5.1.346 Open Access : ISSN : 1848-7718 Original scientific paper http://www.pub.iapchem.org/ojs/index.php/admet/index Biorelevant dissolution of candesartan
More informationPharmacokinetics Dr. Iman Lec. 3
Pharmacokinetics r. Iman Lec. 3 Pharmacokinetics A dequate drug doses must be delivered to the target organ to get therapeutic but not toxic levels. So, pharmacokinetic examines the movement of drug over
More informationInvited Review. Introduction
BIOPHARMACEUTICS & DRUG DISPOSITION Biopharm. Drug Dispos. 34: 2 28 (2013) Published online 8 October 2012 in Wiley Online Library (wileyonlinelibrary.com).1810 Invited Review Absolute abundance and function
More informationUsing virtual populations to solve drug development problems. Iain Gardner Head of Translational DMPK Science SIMCYP
Using virtual populations to solve drug development problems Iain Gardner Head of Translational DMPK Science SIMCYP Prediction of human PK (PD) in virtual individuals In vitro system In vitro CLu int Scaling
More informationTill min underbara och tålmodiga familj utan lagom mycket lek skulle detta aldrig gått att genomföra.
Till min underbara och tålmodiga familj utan lagom mycket lek skulle detta aldrig gått att genomföra. List of Papers This thesis is based on the following papers, which are referred to in the text by
More informationTHE DIGESTIVE SYSTEM
THE DIGESTIVE SYSTEM Composed of two parts: 1. 2. There are 4 main parts of digestion: 1. Ingestion: 2. Digestion: a. Mechanical Digestion: Example: b. Chemical Digestion: Example: 3. Absorption: 4. Egestion:
More informationEnhancement of oral bioavailability of insulin in humans
Neuroendocrinology Letters Volume 30 No. 1 2009 Enhancement of oral bioavailability of insulin in humans Adnan Badwan 1, Mayas Remawi 1, Nidal Qinna 1,4, Amani Elsayed 1,5, Tawfiq Arafat 2, Munther Melhim
More informationStrategies for Developing and Validating PBPK Models for Extrapolation to Unstudied Population
Strategies for Developing and Validating PBPK Models for Extrapolation to Unstudied Population Nina Isoherranen Department of Pharmaceutics University of Washington Processes driving drug disposition are
More informationBiopharmaceutical aspects of intestinal drug absorption
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 257 Biopharmaceutical aspects of intestinal drug absorption Regional permeability and absorption-modifying excipients
More informationApplication of Physiologically Based Pharmacokinetic Modeling in. Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal
TITLE: Application of Physiologically Based Pharmacokinetic Modeling in Understanding Bosutinib Drug-Drug Interactions: Importance of Intestinal P-Glycoprotein AUTHORS: Shinji Yamazaki, Cho-Ming Loi, Emi
More informationCONTROLLED-RELEASE & SUSTAINED-RELEASE DOSAGE FORMS. Pharmaceutical Manufacturing-4
CONTROLLED-RELEASE & SUSTAINED-RELEASE DOSAGE FORMS Pharmaceutical Manufacturing-4 The improvement in drug therapy is a consequence of not only the development of new chemical entities but also the combination
More informationA compartmental absorption and transit model for estimating oral drug absorption
International Journal of Pharmaceutics 186 (1999) 119 125 www.elsevier.com/locate/promis A compartmental absorption and transit model for estimating oral drug absorption Lawrence X. Yu a, *, Gordon L.
More informationGastrointestinal Anatomy and Physiology. Bio 219 Napa Valley College Dr. Adam Ross
Gastrointestinal Anatomy and Physiology Bio 219 Napa Valley College Dr. Adam Ross Functions of digestive system Digestion Breakdown of food (chemically) using enzymes, acid, and water Absorption Nutrients,
More informationDigestion and Absorption
Digestion and Absorption Digestion and Absorption Digestion is a process essential for the conversion of food into a small and simple form. Mechanical digestion by mastication and swallowing Chemical digestion
More informationSupporting Information Figure S1. Study day diagram. The MRI scans were more frequent for
ASSOCIATED CONTENT Supporting Information. Supporting Information Figure S1. Study day diagram. The MRI scans were more frequent for the first half an hour when gastric emptying was expected to be faster.
More informationChromatography on Immobilized Artificial Membrane
Chromatography on Immobilized Artificial Membrane Principles of measuring compounds affinity to phospholipids using immobilized artificial membrane chromatography Chromatography on Immobilized Artificial
More informationDeciphering nifedipine in vivo delivery from modified release dosage forms: Identification of food effect
Acta Pharm. 65 (2015) 427 441 DOI: 10.1515/acph-2015-0039 Original research paper Deciphering nifedipine in vivo delivery from modified release dosage forms: Identification of food effect MARIJA ILIĆ*
More informationEffect of Excipients on Dissolution: Case Studies with Bio-relevant/ Hydro-alcoholic Media
Effect of Excipients on Dissolution: Case Studies with Bio-relevant/ Hydro-alcoholic Media Sandip B. Tiwari, Ph.D. Technical Director: South Asia Colorcon Asia Pvt. Ltd., Goa, India DISSO-INDIA 2013, May
More informationChapter 20 The Digestive System Exam Study Questions
Chapter 20 The Digestive System Exam Study Questions 20.1 Overview of GI Processes 1. Describe the functions of digestive system. 2. List and define the four GI Processes: 20.2 Functional Anatomy of the
More informationDigestive System. How your body obtains nutrients. Wednesday, March 2, 16
Digestive System How your body obtains nutrients Vocabulary Ingestion: food enters the system Physical and enzymatic breakdown begins Digestion: Further breakdown Chemical/enzymatic Vocabulary Absorption:
More informationPhysiologically Based Pharmacokinetic Modeling of Intestinal First-Pass Metabolism of CYP3A Substrates with High Intestinal Extraction S
Supplemental material to this article can be found at: http://dmd.aspetjournals.org/content/suppl/2011/06/01/dmd.111.039248.dc1 0090-9556/11/3909-1633 1642$25.00 DRUG METABOLISM AND DISPOSITION Vol. 39,
More informationDevelopment of Nutrient Delivery Systems: Ingredients & Challenges
Development of Nutrient Delivery Systems David Julian McClements and Hang Xiao Department of Food Science University of Massachusetts Development of Nutrient Delivery Systems: Ingredients & Challenges
More informationVolume 1(3) May-June 2013 Page 351
ISSN: 2321-5674(Print) BIOAVAILABILITY: CRITERIA FOR APPROVING A DRUG PRODUCT FOR MARKETING Sandhya Singh 1, Faheem Ajmal Ansari 1, Shravan Paswan 2*, Rnjan Kumar Sharma 2, Alok Ranjan Gaur 3 1 Azad Institute
More informationBiowaiver and Dissolution Profile Comparison
Biowaiver and Dissolution Profile Comparison Triporn Wattananat Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011 Biowaiver Outline: 1. Introduction 2. Biopharmaceutics Classification
More informationGastrointestinal Transit and Drug Absorption
February 2002 Biol. Pharm. Bull. 25(2) 149 164 (2002) 149 Review Gastrointestinal Transit and Drug Absorption Toshikiro KIMURA* and Kazutaka HIGAKI Faculty of Pharmaceutical Sciences, Okayama University,
More informationThe Future of In Vitro Systems for the Assessment of Induction and Suppression of Enzymes and Transporters
The Future of In Vitro Systems for the Assessment of Induction and Suppression of Enzymes and Transporters AAPS, San Diego November 6 th, 2014 Andrew Parkinson, XPD Consulting Lisa Almond, Simcyp-Certara
More informationEarly BioPharm Risk Assessment in Discovery. Linette Ruston PCF9 17 th September 2010, Barcelona
Early BioPharm Risk Assessment in Discovery Linette Ruston PCF9 17 th September 2010, Barcelona Outline Background Why? How? cmad and early absorption simulation Case Studies & Examples Summary 2 Poor
More information7. SUMMARY, CONCLUSION AND RECOMMENDATIONS
211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability
More informationBiopharmaceutics Drug Disposition Classification System (BDDCS) and Its Application in Drug Discovery and Development
Biopharmaceutics Drug Disposition Classification System (BDDCS) and Its Application in Drug Discovery and Development Leslie Z. Benet, Ph.D. Professor of Bioengineering and Therapeutic Sciences University
More information5 Application of the ESR online-method for the monitoring of nanocapsule digestion
5 Application of the ESR online-method for the monitoring of nanocapsule digestion 5.1 Introduction The oral use of nanocapsules has received considerable attention in recent years because the bioavailability
More informationIncludes mouth, pharynx, esophagus, stomach, small intestine, large intestine, rectum, anus. Salivary glands, liver, gallbladder, pancreas
Chapter 14 The Digestive System and Nutrition Digestive System Brings Nutrients Into the Body The digestive system includes Gastrointestinal (GI) tract (hollow tube) Lumen: space within this tube Includes
More informationNutrition and Digestion
Nutrition and Digestion Classes of Nutrients Carbohydrates Lipids Proteins Minerals Vitamins Water Macronutrients Carbon-containing compounds Energy and raw material Includes carbohydrates, lipids, & proteins
More informationDigestive System. Why do we need to eat? Growth Maintenance (repair tissue) Energy
Digestive System Why do we need to eat? Growth Maintenance (repair tissue) Energy Nutrients Nutrient = chemical that must be obtained by an organism from it s environment in order to survive; nutrients
More informationMechanistic Modeling of in vitro Assays to Improve in vitro/in vivo Extrapolation
Mechanistic Modeling of in vitro Assays to Improve in vitro/in vivo Extrapolation Grace Fraczkiewicz Viera Lukacova Jim Mullin 1 OVERVIEW MembranePlus a software platform for simulation of in vitro transport
More informationHigh-Absorbable Ferric Pyrophosphate for Iron Supplement. Ferrsorb
High-Absorbable Ferric Pyrophosphate for Iron Supplement R Ferrsorb Ferrsorb is iron supplement which is absorbed efficiently into the body without impairing taste and texture of various foods. It can
More information